Medical Management of Aortic Disease: If They Don’t Need Surgery, What Do They Need?

Mujtaba Saeed; Maan Malahfji

doi:10.14797/mdcvj.1192

Medical Management of Aortic Disease: If They Don’t Need Surgery, What Do They Need?

Methodist DeBakey Cardiovascular Journal

Volume 19 (2023): Issue 2

By: Mujtaba Saeed and Maan Malahfji

Open Access

|Mar 2023

Abstract

Management of aortic disease has evolved significantly over the past few decades. A preemptive diagnostic approach with a multidisciplinary team and shared decision-making has led to improved clinical outcomes. Surgery is the cornerstone of management for most aortic conditions; however, medical therapy is now an important adjunctive therapy in most if not all patients. Herein, we review the role and evidence behind medical management of patients with aortic disease.

References

Isselbacher EM, Preventza O, Black JH, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Dec 13;146(24):e334–e482. doi: 10.1161/CIR.0000000000001106
Open DOI Search in Google Scholar Back to article
Danyi P, Elefteriades JA, Jovin IS. Medical therapy of thoracic aortic aneurysms: are we there yet? Circulation. 2011 Sep 27;124(13):1469–76. doi: 10.1161/CIRCULATIONAHA.110.006486
Open DOI Search in Google Scholar Back to article
Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008 Jun 26;358(26):2787–95. doi: 10.1056/NEJMoa0706585
Open DOI Search in Google Scholar Back to article
Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg. 2004 Dec;78(6):2106–10; discussion 2110-1. doi: 10.1016/j.athoracsur.2004.05.088
Open DOI Search in Google Scholar Back to article
Stein LH, Berger J, Tranquilli M, Elefteraides JA. Effect of statin drugs on thoracic aortic aneurysms. Am J Cardiol. 2013 Oct 15;112(8):1240–5. doi: 10.1016/j.amjcard.2013.05.081
Open DOI Search in Google Scholar Back to article
Jovin IS, Duggal M, Ebisu K, et al. Comparison of the effect on long-term outcomes in patients with thoracic aortic aneurysms of taking versus not taking a statin drug. Am J Cardiol. 2012 Apr 1;109(7):1050–4. doi: 10.1016/j.amjcard.2011.11.038
Open DOI Search in Google Scholar Back to article
Allar BG, Swerdlow NJ, de Guerre LEVM, et al. Preoperative statin therapy is associated with higher 5-year survival after thoracic endovascular aortic repair. J Vasc Surg. 2021 Dec;74(6):1996–2005. doi: 10.1016/j.jvs.2021.05.057
Open DOI Search in Google Scholar Back to article
Kent KC, Zwolak RM, Egorova NN, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010 Sep;52(3):539–48. doi: 10.1016/j.jvs.2010.05.090
Open DOI Search in Google Scholar Back to article
Gadowski GR, Pilcher DB, Ricci MA. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg. 1994 Apr;19(4):727–31. doi: 10.1016/s0741-5214(94)70048-6
Open DOI Search in Google Scholar Back to article
Xiong X, Wu Z, Qin X, et al. Meta-analysis suggests statins reduce mortality after abdominal aortic aneurysm repair. J Vasc Surg. 2022 Jan;75(1):356–362.e4. doi: 10.1016/j.jvs.2021.06.033
Open DOI Search in Google Scholar Back to article
Wemmelund H, Høgh A, Hundborg HH, Thomsen RW, Johnsen SP, Lindholt JS. Statin use and rupture of abdominal aortic aneurysm. Br J Surg. 2014 Jul;101(8):966–75. doi: 10.1002/bjs.9517
Open DOI Search in Google Scholar Back to article
Smith, SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006 May 16;113(19):2363–72. doi: 10.1161/CIRCULATIONAHA.106.174516
Open DOI Search in Google Scholar Back to article
Chung AWY, Yang HH, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res. 2008 Apr 25;102(8):e73–85. doi: 10.1161/CIRCRESAHA.108.174367
Open DOI Search in Google Scholar Back to article
Pasternak B, Inghammar M, Svanström H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018 Mar 8;360:k678. doi: 10.1136/bmj.k678
Open DOI Search in Google Scholar Back to article
Gopalakrishnan C, Bykov K, Fischer MA, Connolly JG, Gagne JJ, Fralick M. Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection. JAMA Intern Med. 2020 Dec 1;180(12):1596–1605. doi: 10.1001/jamainternmed.2020.4199
Open DOI Search in Google Scholar Back to article
Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol. 2010 Mar 2;55(9):841–57. doi: 10.1016/j.jacc.2009.08.084
Open DOI Search in Google Scholar Back to article
Hatzaras IS, Bible JE, Koullias GJ, Tranquilli M, Singh M, Elefteriades JA. Role of exertion or emotion as inciting events for acute aortic dissection. Am J Cardiol. 2007 Nov 1;100(9):1470–2. doi: 10.1016/j.amjcard.2007.06.039
Open DOI Search in Google Scholar Back to article
Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005 Dec 3;366(9501):1965–76. doi:10.1016/S0140-6736(05)67789-6
Open DOI Search in Google Scholar Back to article
Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006 Apr 7;312(5770):117–21. doi: 10.1126/science.1124287
Open DOI Search in Google Scholar Back to article
Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994 May 12;330(19):1335–41. doi: 10.1056/NEJM199405123301902
Open DOI Search in Google Scholar Back to article
Mullen M, Jin XY, Child A, et al. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet. 2019 Dec 21;394(10216):2263–2270. doi: 10.1016/S0140-6736(19)32518-8
Open DOI Search in Google Scholar Back to article
Groenink M, den Hartog AW, Franken R, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J. 2013 Dec;34(45):3491–500. doi: 10.1093/eurheartj/eht334
Open DOI Search in Google Scholar Back to article
Lacro RV, Dietz HC, Sleeper LA, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med. 2014 Nov 27;371(22):2061–71. doi: 10.1056/NEJMoa1404731
Open DOI Search in Google Scholar Back to article
Al-Abcha A, Saleh Y, Mujer M, et al. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome. Am J Cardiol. 2020 Aug 1;128:101–106. doi: 10.1016/j.amjcard.2020.04.034
Open DOI Search in Google Scholar Back to article
Gallo EM, Loch DC, Habashi JP, et al. Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2014 Jan;124(1):448–60. doi: 10.1172/JCI69666
Open DOI Search in Google Scholar Back to article
Brooke BS, Arnaoutakis G, McDonnell NB, Black JH 3rd. Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. J Vasc Surg. 2010 Jan;51(1):131–8; discussion 138-9. doi: 10.1016/j.jvs.2009.08.019
Open DOI Search in Google Scholar Back to article
Lum YW, Brooke BS, Black JH 3rd. Contemporary management of vascular Ehlers-Danlos syndrome. Curr Opin Cardiol. 2011 Nov;26(6):494–501. doi: 10.1097/HCO.0b013e32834ad55a
Open DOI Search in Google Scholar Back to article
Frank M, Adham S, Seigle S, et al. Vascular Ehlers-Danlos Syndrome: Long-Term Observational Study. J Am Coll Cardiol. 2019 Apr 23;73(15):1948–1957. doi:10.1016/j.jacc.2019.01.058
Open DOI Search in Google Scholar Back to article
Baderkhan H, Wanhainen A, Stenborg A, Stattin EL, Björck M. Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome. Eur J Vasc Endovasc Surg. 2021 Feb;61(2):326–331. doi: 10.1016/j.ejvs.2020.10.020
Open DOI Search in Google Scholar Back to article
Ong KT, Perdu J, de Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010 Oct 30;376(9751):1476–84. doi: 10.1016/S0140-6736(10)60960-9
Open DOI Search in Google Scholar Back to article
Erbel R, Abyohans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014 Nov 1;35(41):2873–926. doi: 10.1093/eurheartj/ehu281
Open DOI Search in Google Scholar Back to article
Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg. 1970 Sep;10(3):237–47. doi: 10.1016/s0003-4975(10)65594-4
Open DOI Search in Google Scholar Back to article
Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation. 2005 Dec 13;112(24):3802–13. doi: 10.1161/CIRCULATIONAHA.105.534198
Open DOI Search in Google Scholar Back to article
Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol. 2010 Apr 6;55(14):e27–e129. doi: 10.1016/j.jacc.2010.02.015
Open DOI Search in Google Scholar Back to article
Hong JC, Le Huu A, Preventza O. Medical or endovascular management of acute type B aortic dissection. J Thorac Cardiovasc Surg. 2022 Oct;164(4):1058–1065. doi: 10.1016/j.jtcvs.2021.03.127
Open DOI Search in Google Scholar Back to article
Suzuki T, Isselbacher EM, Nienaber CA, et al. Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol. 2012 Jan 1;109(1):122–7. doi: 10.1016/j.amjcard.2011.08.012
Open DOI Search in Google Scholar Back to article
Chen SW, Chan YH, Lin CP, et al. Association of Long-term Use of Antihypertensive Medications With Late Outcomes Among Patients With Aortic Dissection. JAMA Netw Open. 2021 Mar 1;4(3):e210469. doi: 10.1001/jamanetworkopen.2021.0469
Open DOI Search in Google Scholar Back to article
Svensson LG, Arafat A, Roselli EE, et al. Inflammatory disease of the aorta: patterns and classification of giant cell aortitis, Takayasu arteritis, and nonsyndromic aortitis. J Thorac Cardiovasc Surg. 2015 Feb;149(2 Suppl):S170–5. doi: 10.1016/j.jtcvs.2014.08.003
Open DOI Search in Google Scholar Back to article
Gornik HL, Creager MA. Aortitis. Circulation. 2008 Jun 10;117(23):3039–51. doi: 10.1161/CIRCULATIONAHA.107.760686
Open DOI Search in Google Scholar Back to article
Leone O, Corsini A, Pacini D, et al. The complex interplay among atherosclerosis, inflammation, and degeneration in ascending thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2020 Dec;160(6):1434–1443.e6. doi: 10.1016/j.jtcvs.2019.08.108
Open DOI Search in Google Scholar Back to article
Pacini D, Leone O, Turci S, et al. Incidence, etiology, histologic findings, and course of thoracic inflammatory aortopathies. Ann Thorac Surg. 2008 Nov;86(5):1518–23. doi: 10.1016/j.athoracsur.2008.07.039
Open DOI Search in Google Scholar Back to article
Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995 Apr 1;122(7):502–7. doi: 10.7326/0003-4819-122-7-199504010-00004
Open DOI Search in Google Scholar Back to article
Stone JH, Khosroshahi A, Deshpande V, Stone JR. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res (Hoboken). 2010 Mar;62(3):316–22. doi: 10.1002/acr.20095
Open DOI Search in Google Scholar Back to article
Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020 Jan;79(1):19–30. doi: 10.1136/annrheumdis-2019-215672
Open DOI Search in Google Scholar Back to article
Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA. 2016 Jun 14;315(22):2442–58. doi: 10.1001/jama.2016.5444
Open DOI Search in Google Scholar Back to article
Hoffman GS, Cid MC, Hellmann DB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002 May;46(5):1309–18. doi: 10.1002/art.10262
Open DOI Search in Google Scholar Back to article
Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007 Mar;56(3):1000–9. doi: 10.1002/art.22404
Open DOI Search in Google Scholar Back to article
Stone JH, Tuckwell K, Dimonaco S, et al. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med. 2017 Jul 27;377(4):317–328. doi: 10.1056/NEJMoa1613849
Open DOI Search in Google Scholar Back to article
Jover JA, Hernández-García C, Morado IC, Vargas E, Bañares A, Fernàndez-Gutiérrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001 Jan 16;134(2):106–14. doi: 10.7326/0003-4819-134-2-200101160-00010
Open DOI Search in Google Scholar Back to article
ClinicalTrials.gov [Internet]. Bethesda, MD: US National Library of Medicine; c2023. Effect of Preoperative Exercise on Postoperative Outcome in AAA Patients: Pilot Study; 2016 Jul 27 [cited 2023 Jan 26]. Available from: https://clinicaltrials.gov/show/NCT02845167
Search in Google Scholar Back to article
Fuglsang S, Heiberg J, Hjortdal VE, Laustsen S. Exercise-based cardiac rehabilitation in surgically treated type-A aortic dissection patients. Scand Cardiovasc J. 2017 Apr;51(2):99–105. doi: 10.1080/14017431.2016.1257149
Open DOI Search in Google Scholar Back to article
Evangelista A, Pineda V, Guala A, et al. False Lumen Flow Assessment by Magnetic Resonance Imaging and Long-Term Outcomes in Uncomplicated Aortic Dissection. J Am Coll Cardiol. 2022;79(24):2415–2427. doi: 10.1016/j.jacc.2022.04.017
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1192 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 70 - 77

Submitted on: Nov 24, 2022

Accepted on: Jan 13, 2023

Published on: Mar 7, 2023

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

aortitis,

aortic aneurysm,

aortic dissection

© 2023 Mujtaba Saeed, Maan Malahfji, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 19 (2023): Issue 2